Análise de custo-efetividade dos stents farmacológicos e não farmacológicos na doença coronariana

Ferreira, Esmeralci; Araújo, Denizar Vianna; Azevedo, Vitor Manuel Pereira; Rodrigues, Cyro Vargues; Ferreira Júnior, Alcides; Junqueira, Camillo de Lellis; Amino, José Geraldo de Castro; Farias, Mara Lucia; Farias Neto, Antonio; Albuquerque, Denilson Campos de.
Arq. bras. cardiol ; 94(3): 306-312, mar. 2010. ilus, tab
Artigo em Português | LILACS | ID: lil-545815

Documentos relacionados

  1. Analysis of the cost-effectiveness of drug-eluting and bare-metal stents in coronary disease.
  2. Economic Evaluation of the Use of Drug-Eluting Stents versus Bare-Metal Stents in Adults with Ischemic Cardiomyopathy Requiring Angioplasty.
  3. An Economic Analysis of Stent Grafts for Treatment of Vascular Access Stenosis: Point-of-Care and Medicare Perspectives in the United States.
  4. Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitäts Trial (BASKET): an 18-month analysis.
  5. How real can we get in generating real world evidence? Exploring the opportunities of routinely collected administrative data for evaluation of medical devices.
  6. Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET).
  7. Cost-effectiveness analysis of enhancements to angioplasty for infrainguinal arterial disease.
  8. [Economic impact of the taxus coronary stent: implications for the Spanish healthcare system].
  9. Cost-Effectiveness of Percutaneous Coronary Intervention Compared With Medical Therapy for Ischemic Heart Disease in Japan.
  10. Cost-effectiveness of drug-eluting stents in a US Medicare setting:a cost-utility analysis with 3-year clinical follow-up data.